P. Portincasa, M. Krawczyk, W. Smyk, F. Lammert, A. Di Ciaula
European journal of clinical investigation, 2020
Initial evidence from China suggests that most vulnerable subjects to COVID‐19 infection suffer from pre‐existing illness, including metabolic abnormalities. The pandemic characteristics and high‐lethality rate of COVID‐19 infection have raised concerns about interactions between virus pathobiology and components of the metabolic syndrome.
Cited by 37 publications.
Field of study: Medicine